XML 68 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Stock Options) (Details) - USD ($)
3 Months Ended 6 Months Ended
Jan. 31, 2023
Oct. 31, 2022
Jan. 31, 2023
Jan. 31, 2022
Weighted Average Remaining Contractual Term (Years)        
Outstanding, Ending Balance     4 years 1 month 9 days  
Aggregated Intrinsic Value        
Outstanding, Ending Balance $ 0   $ 0  
Stock options        
Awards (In Shares)        
Outstanding, Beginning Balance (in shares) 474,020 483,480 483,480  
Expired/canceled (in shares) (182,400) (9,460)    
Outstanding, Ending Balance (in shares) 291,620 474,020 291,620  
Exercisable, Ending Balance (in shares) 246,740   246,740  
Vested and Expected to Vest, Ending Balance (in shares) 289,009   289,009  
Weighted Average Exercise Price (Per Share)        
Outstanding, Beginning Balance (in dollars per share) $ 24.38 $ 24.43 $ 24.43  
Expired/canceled (in dollars per share) 24.75 26.55    
Outstanding, Ending Balance (in dollars per share) 24.15 $ 24.38 24.15  
Exercisable, Ending Balance (in dollars per share) 25.29   25.29  
Vested and Expected to Vest, Ending Balance (in dollars per share) $ 24.21   $ 24.21  
Weighted Average Remaining Contractual Term (Years)        
Exercisable, Ending Balance     3 years 6 months 10 days  
Vested And Expected To Vest, Ending Balance     4 years 29 days  
Aggregated Intrinsic Value        
Exercisable, Ending Balance $ 0   $ 0  
Vested and Expected to Vest, Ending Balance $ 0   $ 0  
Additional Disclosures        
Exercise price, lower range limit (in dollars per share)     $ 17.88  
Exercise price, upper range limit (in dollars per share)     $ 33.94  
Total intrinsic value relating to stock-based awards exercised during the period     $ 0 $ 7,000
Stock options | Maximum        
Additional Disclosures        
Contractual term (in years)     10 years  
Stock options | Tranche Two        
Additional Disclosures        
Vesting period     5 years